Understanding Nearsightedness

Myopia Management with MiSight and Atropine

Understanding Nearsightedness

Nearsightedness happens when the eye grows too long, causing distant objects to look blurry. Managing this growth early makes a lasting difference.

Myopia starts when light focuses in front of the retina because the eyeball is too long. Children see close objects clearly but struggle with things far away. The condition usually worsens through the school years and stabilizes in early adulthood.

Regular glasses correct blurry vision but do not slow eye growth. Without active management, prescriptions become stronger each year, and the risk of future eye disease rises.

The Myopia Epidemic

The Myopia Epidemic

Rising myopia rates have prompted global health leaders to call for proactive care rather than simple vision correction.

Experts predict that nearly half of the world’s population could be nearsighted by 2050. Studies show that by their late teens, almost 60 percent of U.S. children are myopic, with high myopia also increasing.

Leading organizations agree that managing myopia progression is now essential for children’s eye health.

  • The World Society of Paediatric Ophthalmology and Strabismus supports preventive care.
  • The American Academy of Ophthalmology formed a task force with medical partners to address childhood myopia.
  • The World Council of Optometry calls myopia management an obligation of optometrists.
  • The American Optometric Association provides evidence-based guidelines for treatment.

Risks of Uncontrolled Myopia

Risks of Uncontrolled Myopia

High or rapidly progressing myopia raises the chance of serious eye problems later in life.

Myopia increases eye pressure risk, which can damage the optic nerve and lead to vision loss.

People with high myopia often develop cataracts earlier, causing cloudy vision that may need surgical correction.

Excessive eye elongation stretches the retina, making detachment more likely and creating an emergency that threatens sight.

Severe myopia can damage the macula, the area responsible for sharp central vision, leading to permanent vision loss.

Early Intervention for Long-Term Eye Health

Starting treatment in childhood improves outcomes and lowers the risk of future eye disease.

Routine eye exams before kindergarten catch early signs such as squinting or holding books close. Detecting issues early lets us act before myopia accelerates.

Introducing treatments like low-dose atropine or MiSight lenses at the first signs of myopia slows abnormal eye growth. Children who begin management early are less likely to develop high myopia.

Atropine Eye Drops and MiSight Contact Lenses

Atropine Eye Drops and MiSight Contact Lenses

These two proven options can be used alone or together, depending on each child’s needs.

Low-dose atropine drops are placed in the eyes at bedtime. They relax the focusing system and reduce signals that trigger eye elongation.

Atropine partially blocks receptors linked to eye growth, helping curb myopia progression with minimal effect on near vision.

Studies show that concentrations from 0.01 percent to 0.025 percent can slow myopia progression by around 50 percent or more with few side effects.

MiSight daily disposable lenses are FDA-approved for children ages 7 to 14. They correct vision while actively slowing myopia progression.

The lens center provides clear vision, while surrounding rings create peripheral defocus that signals the eye to slow growth.

In a three-year study, children wearing MiSight lenses showed 59 percent less myopia progression than those with standard lenses. Over six years, prescription increases stayed under one diopter on average.

Safety and Special Considerations

Safety and Special Considerations

Both treatments have strong safety records when monitored by an eye care professional.

Using atropine drops and MiSight lenses together tackles myopia from two angles. Atropine works like a brake on eye growth, and MiSight lenses guide light to reinforce that signal.

  • Atropine drops slow the biological growth process.
  • MiSight lenses manage light focus to reduce growth signals.

Low doses cause few side effects. Regular checkups ensure the dosage remains effective and prevent rebound effects.

Daily disposables promote hygiene and lower infection risk. Clinical trials confirm safety when lenses are used and replaced properly.

Myopia Management Appointments

Myopia Management Appointments

Consistent monitoring lets us tailor care as your child grows.

We measure refractive error, eye length, and corneal shape to create a customized management plan.

Follow-ups track prescription changes and eye growth, allowing timely adjustments to lenses or drop dosages.

Frequently Asked Questions

Frequently Asked Questions

The following answers address common concerns about myopia management.

Most children continue treatment for several growth years. We reassess progress regularly to decide when it is safe to taper or stop.

Low-dose atropine usually leaves near vision clear, and MiSight lenses are comfortable for daily wear. Side effects are uncommon when guidelines are followed.

Yes. Combining therapies can enhance results because each works through a different mechanism. We design a plan tailored to your child’s unique needs.

Partner With Us for Your Child’s Clearer Future

Partner With Us for Your Child’s Clearer Future

Our eye care team has decades of experience guiding families through myopia management. We are committed to providing personalized, research-based care that supports lifelong vision health.